A Retrospective Observational Research Study To Describe The Real World Use Of Bosutinib In The Uk And Netherlands

Trial Profile

A Retrospective Observational Research Study To Describe The Real World Use Of Bosutinib In The Uk And Netherlands

Completed
Phase of Trial: Phase IV

Latest Information Update: 09 Mar 2017

At a glance

  • Drugs Bosutinib (Primary)
  • Indications Chronic myeloid leukaemia
  • Focus Pharmacogenomic; Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.
    • 06 Dec 2016 Status changed from active, no longer recruiting to completed,according to the results published at the 58th Annual Meeting and Exposition of the American Society of Hematology.
    • 17 Aug 2016 Planned End Date changed from 31 Jul 2016 to 1 Oct 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top